ABUS vs COUR
Comparison between Arbutus Biopharma Corp (ABUS, Company) and Coursera Inc (COUR, Company).
ABUS is from the Healthcare sector, while COUR is from the Consumer Defensive sector.
5-Year PerformanceABUS has outperformed COUR, delivering a return of +7.0% compared to -34.4%
ABUS vs COUR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
ABUS vs COUR - Historical Returns
Returns include dividend reinvestment.
ABUS vs COUR - Annual Returns (2015 - 2026)
Returns include dividend reinvestment.
| Year | ABUS | COUR |
|---|---|---|
| 2026 | -4.61% | -24.44% |
| 2025 | +46.20% | -13.21% |
| 2024 | +26.25% | -55.94% |
| 2023 | +12.11% | +56.84% |
| 2022 | -41.46% | -53.68% |
| 2021 | +6.87% | -45.69% |
| 2020 | +20.75% | N/A |
| 2019 | -30.50% | N/A |
| 2018 | -29.72% | N/A |
| 2017 | +102.00% | N/A |
| 2016 | -45.80% | N/A |
| 2015 | -57.62% | N/A |
ABUS vs COUR Drawdown Comparison
The maximum drawdown for ABUS was -92.96%, occurring on Oct 9, 2019. This drawdown has not yet recovered.
The maximum drawdown for COUR was -91.22%, occurring on May 14, 2026. This drawdown has not yet recovered.
The current ABUS drawdown is -63.16%. The current COUR drawdown is -90.78%.
| Rank | ABUS | COUR |
|---|---|---|
| #1 | -92.96% Aug 2, 2018 - Oct 9, 2019 | -91.22% Apr 7, 2021 - May 14, 2026 |
| #2 | -76.67% Aug 3, 2015 - Jul 11, 2018 | N/A |
| #3 | -8.12% Jul 13, 2018 - Aug 1, 2018 | N/A |
Correlation
Correlation between ABUS and COUR is -0.20 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks